Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AstraZeneca PLC - American Depositary Shares (NQ:AZN)

85.31 +1.66 (+1.98%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,902,596
Open 84.30
Bid (Size) 85.31 (1)
Ask (Size) 85.35 (1)
Prev. Close 83.65
Today's Range 83.84 - 85.50
52wk Range 61.24 - 84.61
Shares Outstanding N/A
Dividend Yield 1.21%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
FDA Greenlights Jazz and Roche's Zepzelca-Tecentriq for ES-SCLC Maintenance, Reshaping Lung Cancer Treatment Landscape
In a pivotal moment for oncology, the U.S. Food and Drug Administration (FDA) on October 2, 2025, granted approval for the innovative combination of Jazz Pharmaceuticals' (NASDAQ: JAZZ) Zepzelca... 
Via MarketMinute
2 Under-The-Radar Health-Tech Stocks With Surging Momentum Scores
Two under-the-radar health-tech stocks are seeing their Momentum scores surge in Benzinga's Edge Stock Rankings. 
Via Benzinga

Performance

YTD
+29.5%
+29.5%
1 Month
+6.4%
+6.4%
3 Month
+22.8%
+22.8%
6 Month
+15.4%
+15.4%
1 Year
+7.2%
+7.2%

More News

Read More
Investing in These 3 Quantum Computing Stocks Could Be a Once-in-a-Lifetime Opportunity
Via The Motley Fool
AstraZeneca Plans Ordinary Share Listing In US – Find Out More On The Harmonized Listing Structure
Via Stocktwits
Amgen Surges on Repatha Expansion, Manufacturing Boost, and Strong Earnings
Via MarketMinute
Topics Economy Intellectual Property Stocks
AstraZeneca Stock Is Up 10% on Tariff News. But Is the Pharmaceutical Giant a Buy?
Via The Motley Fool
Topics Government World Trade
Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape
Via MarketMinute
Topics Artificial Intelligence Economy Government
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk
Via Benzinga
Topics ETFs
AstraZeneca's Strategic Listing Harmonization: A Unified Global Platform for Growth
Via MarketMinute
Topics Economy
GSK Leaps Into Buy Zone On Surprise Departure Of CEO Emma Walmsley
Via Investor's Business Daily
AstraZeneca Moves From ADRs To NYSE Listing
Via Benzinga
ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated highly statistically significant and clinically meaningful improvement in invasive disease-free survival vs. T-DM1 in DESTINY-Breast05 Phase III trial
From AstraZeneca
Via Business Wire
3 Magnificent Stocks Under $100 to Buy Right Now
Via The Motley Fool
Your AstraZeneca Medicine Could Be Cheaper As Much As 70%
Via Benzinga
AstraZeneca launches direct-to-consumer platform to expand access to medications for US patients, including those living with chronic conditions
From AstraZeneca
Via Business Wire
Trump's 100% Pharmaceutical Tariff: The $270 Billion Manufacturing War That Could Reshape Your Medicine Cabinet
Via Benzinga
Topics Government World Trade
Trump Shocks Pharma With 100% Tariff On Imported Drugs Unless Companies Build In America
Via Stocktwits
Topics Government
Moderna Stands By UK As Pharma Giants Criticize Pricing, UK Secures First Onshore mRNA Vaccine Production Centre
Via Benzinga
United Kingdom The Worst European Country For Drug Prices: Eli Lilly CEO
Via Benzinga
ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab granted Priority Review in the US as 1st-line treatment for patients with HER2-positive metastatic breast cancer
From AstraZeneca
Via Business Wire
European Advisory Panel Recommends Two AstraZeneca Drugs For Approval
Via Benzinga
Big Pharma's Epicenter Shift: Eli Lilly and the Reshaping of the Weight-Loss Drug Market
Via MarketMinute
Topics Economy Intellectual Property
Is the Market Bullish or Bearish on AstraZeneca?
Via Benzinga
Growth Titans: Eli Lilly's Weight-Loss Surge vs. Johnson & Johnson's Diversified Might
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
The Pharmaceutical Revolution: AI, Gene Therapies, and Obesity Drugs Reshape a Trillion-Dollar Market
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property

Frequently Asked Questions

Is AstraZeneca PLC - American Depositary Shares publicly traded?
Yes, AstraZeneca PLC - American Depositary Shares is publicly traded.
What exchange does AstraZeneca PLC - American Depositary Shares trade on?
AstraZeneca PLC - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for AstraZeneca PLC - American Depositary Shares?
The ticker symbol for AstraZeneca PLC - American Depositary Shares is AZN on the Nasdaq Stock Market
What is the current price of AstraZeneca PLC - American Depositary Shares?
The current price of AstraZeneca PLC - American Depositary Shares is 85.31
When was AstraZeneca PLC - American Depositary Shares last traded?
The last trade of AstraZeneca PLC - American Depositary Shares was at 10/03/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.